Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies

Чип гематоэнцефалического барьера, усиленный гипоксией, воспроизводит функции человеческого барьера и перенос лекарственных препаратов и антител
Donald E. Ingber, Hannah W. Song, Sean P. Palecek, Eric V. Shusta, Liliana Christova Goumnerova, Anna Herland, Olivier Henry, Edward A. Fitzgerald, Tae‐Eun Park, Robert J. Mannix, Nur Mustafaoğlu, Ryan Hasselkus, Rachelle Prantil‐Baun, Alexander L. Watters, Maximilian A. Benz, Henry Sanchez, Heather J. McCrea
2019-06-13

blood-brain barrier chipdrug and antibody transcytosishypoxic differentiationinduced pluripotent stem cell-derived endotheliummicrofluidic organ-on-a-chip
Abstract The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.
1
A microfluidic BBB organ-on-a-chip uses iPSC-derived human brain microvascular endothelium with primary human astrocytes and pericytes.
2
Hypoxic differentiation within a developmentally inspired induction protocol enhances BBB barrier functionality.
3
The BBB Chip selectively transcytoses peptides and antibodies previously observed to cross the BBB in vivo, supporting drug-delivery development.
4
The engineered endothelium expresses high levels of tight-junction proteins and functional efflux pumps.
5
The model recapitulates the high selectivity and barrier function of the human in vivo BBB for at least one week in culture.

Hypoxia-enhanced human blood-brain barrier organ-on-a-chip lined with iPSC-derived brain microvascular endothelium and interfaced with human astrocytes and pericytes

Human BBB barrier function and selective transcytosis/shuttling of drugs, peptides, and therapeutic antibodies under hypoxic differentiation conditions

Publication Details
Publication Date
2019-06-13
Journal
Publisher
ISSN
Cited by
602
Access Type
Author Information
Authors
Donald E. Ingber
Hannah W. Song
Sean P. Palecek
Eric V. Shusta
Liliana Christova Goumnerova
Anna Herland
Olivier Henry
Edward A. Fitzgerald
Tae‐Eun Park
Robert J. Mannix
Nur Mustafaoğlu
Ryan Hasselkus
Rachelle Prantil‐Baun
Alexander L. Watters
Maximilian A. Benz
Henry Sanchez
Heather J. McCrea
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%